146 related articles for article (PubMed ID: 9765242)
1. A new type of cytokine receptor antagonist directly targeting gp130.
Renné C; Kallen KJ; Müllberg J; Jostock T; Grötzinger J; Rose-John S
J Biol Chem; 1998 Oct; 273(42):27213-9. PubMed ID: 9765242
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
[TBL] [Abstract][Full Text] [Related]
3. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
4. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
Modrell B; Liu J; Miller H; Shoyab M
Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
[TBL] [Abstract][Full Text] [Related]
5. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
[TBL] [Abstract][Full Text] [Related]
6. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
7. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
Vernallis AB; Hudson KR; Heath JK
J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
[TBL] [Abstract][Full Text] [Related]
8. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR
J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083
[TBL] [Abstract][Full Text] [Related]
9. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
10. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
Tacken I; Dahmen H; Boisteau O; Minvielle S; Jacques Y; Grötzinger J; Küster A; Horsten U; Blanc C; Montero-Julian FA; Heinrich PC; Müller-Newen G
Eur J Biochem; 1999 Oct; 265(2):645-55. PubMed ID: 10504396
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
[TBL] [Abstract][Full Text] [Related]
12. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
Di Marco A; Gloaguen I; Demartis A; Saggio I; Graziani R; Paonessa G; Laufer R
J Biol Chem; 1997 Sep; 272(37):23069-75. PubMed ID: 9287306
[TBL] [Abstract][Full Text] [Related]
13. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
14. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells.
Koshimizu U; Taga T; Watanabe M; Saito M; Shirayoshi Y; Kishimoto T; Nakatsuji N
Development; 1996 Apr; 122(4):1235-42. PubMed ID: 8620850
[TBL] [Abstract][Full Text] [Related]
15. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
Benigni F; Fantuzzi G; Sacco S; Sironi M; Pozzi P; Dinarello CA; Sipe JD; Poli V; Cappelletti M; Paonessa G; Pennica D; Panayotatos N; Ghezzi P
Blood; 1996 Mar; 87(5):1851-4. PubMed ID: 8634432
[TBL] [Abstract][Full Text] [Related]
16. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
[TBL] [Abstract][Full Text] [Related]
17. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
Shimon I; Yan X; Ray DW; Melmed S
J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512
[TBL] [Abstract][Full Text] [Related]
19. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
20. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
